FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

426265004: Substance with protein kinase inhibitor mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2674879016 Protein kinase inhibitor en Synonym Active Entire term case insensitive SNOMED CT core module
3520809012 Substance with protein kinase inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3559305017 Substance with protein kinase inhibitor mechanism of action en Synonym Active Entire term case insensitive SNOMED CT core module

147 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Substance with protein kinase inhibitor mechanism of action Is a Substance with phosphotransferase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Substance with protein kinase inhibitor mechanism of action Has disposition Protein kinase inhibitor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Temsirolimus Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Substance with protein-tyrosine kinase inhibitor mechanism of action Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Sirolimus Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Everolimus Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Zotarolimus Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Substance with B-Raf inhibitor mechanism of action Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Substance with phosphoinositide 3 kinase inhibitor mechanism of action Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Nintedanib Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Palbociclib Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Product containing protein kinase inhibitor Has active ingredient True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier 1
Ribociclib Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Abemaciclib Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Substance with mitogen-activated protein kinase kinase inhibitor mechanism of action (substance) Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ribociclib succinate Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Alpelisib Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Avapritinib Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Nintedanib esilate Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Trilaciclib Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Trilaciclib dihydrochloride Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Substance with fibroblast growth factor receptor inhibitor mechanism of action (substance) Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Palbociclib 75mg tablets Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dasatinib monohydrate Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dasatinib monohydrate Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Sodium dichloroacetate Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Tepotinib hydrochloride Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Tepotinib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Palbociclib 100mg tablets Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Mobocertinib succinate Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Palbociclib 125mg tablets Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Selumetinib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
vemurafenib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Crizotinib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Bosutinib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dabrafenib mesilate Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dabrafenib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Regorafenib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Nintedanib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Cobimetinib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Tivozanib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Midostaurin Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Palbociclib Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ribociclib Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Tivozanib Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Midostaurin Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Palbociclib 100mg capsules Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Palbociclib 125mg capsules Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Palbociclib 75mg capsules Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ribociclib 200mg tablets Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Tivozanib 1340microgram capsules Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Midostaurin 25mg capsules Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ibrance 75mg capsules (Pfizer Ltd) Has active ingredient True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ibrance 100mg capsules (Pfizer Ltd) Has active ingredient True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Ibrance 125mg capsules (Pfizer Ltd) Has active ingredient True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Kisqali 200mg tablets (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Fotivda 1340microgram capsules (EUSA Pharma (UK) Ltd) Has active ingredient True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Rydapt 25mg capsules (Novartis Pharmaceuticals UK Ltd) Has active ingredient True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Tivozanib 890microgram capsules Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Fotivda 890microgram capsules (EUSA Pharma (UK) Ltd) Has active ingredient True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Binimetinib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Encorafenib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Binimetinib Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Binimetinib 15mg tablets Has active ingredient False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Mektovi 15mg tablets (Pierre Fabre Ltd) Has active ingredient True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dacomitinib Is a False Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Dacomitinib Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Encorafenib Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier
Binimetinib Is a True Substance with protein kinase inhibitor mechanism of action Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start